RSS

Noven Pharmaceuticals

Noven Pharmaceuticals, a subsidiary of Hisamitsu Pharmaceutical, has received approval from the Food and Drug Administration (FDA) for Secuado transdermal system, a transdermal patch formulation for the treatment of adults with schizophrenia Read more

North America